logo

For the Inventor, By the Inventor

Paris, France

Bioprojet


USPTO Granted Patents = 24

% Expired Patents = 12.5



Forward Citations = 53

Loading Chart...
Loading Chart...

49 inventors (with patents filed for the assignee):

goldMedal Jeanne-Marie Lecomte (22 out of 56 patents)

silverMedal Jean-Charles Schwartz (22 out of 62 patents)

bronzeMedal Xavier Ligneau (14 out of 20 patents)

4.  Marc Capet (12 out of 41 patents)

5.  Philippe Robert (12 out of 13 patents)

6.  Nicolas Levoin (10 out of 11 patents)

7.  Isabelle Berrebi-Bertrand (9 out of 11 patents)

8.  Thierry Calmels (7 out of 8 patents)

9.  Olivier Labeeuw (6 out of 8 patents)

10.  Stéphane Krief (5 out of 7 patents)

11.  Xavier Billot (5 out of 6 patents)

12.  Denis Danvy (5 out of 21 patents)

13.  David Perrin (3 out of 7 patents)

14.  Rajamannar Thennati (2 out of 46 patents)

15.  Laurent Landais (2 out of 2 patents)


24 patents:

1. 12134608 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2024-11-05),
2. 12059416 - Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof (2024-08-13),
3. 11306069 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2022-04-19),
4. 11229632 - Combinations of a H3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof (2022-01-25),
5. 11078183 - Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical compositions comprising the same (2021-08-03),
6. 10952987 - Combination of adrenalin with an antidepressant for use in the treatment of shocks (2021-03-23),
7. 9439853 - Form of administration of enkephalinase inhibitor (2016-09-13),
8. 9266867 - Piperidinyl monocarboxylic acids as S1P1 receptor agonists (2016-02-23),
9. 9255101 - 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands (2016-02-09),
10. 9242959 - (Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications (2016-01-26),
11. 9029357 - Benzazole derivatives as histamine H4 receptor ligands (2015-05-12),
12. 8809539 - Dicarboxylic acid derivatives as S1P1 receptor agonists (2014-08-19),
13. 8802678 - [object Object] (2014-08-12),
14. 8486947 - [object Object] (2013-07-16),
15. 8354430 - Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine (2013-01-15),
Bioprojet is a biopharmaceutical company based in Paris, France, specializing in the development of innovative therapies for central nervous system disorders. The organization focuses on research and development in the fields of neuropharmacology and drug delivery systems, aiming to address unmet medical needs through advanced scientific approaches. With a commitment to improving patient outcomes, Bioprojet collaborates with various stakeholders in the healthcare sector to bring its pioneering solutions to market.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Bioprojet
24 Patents

#209 in Paris

#876 in France

#26,595 in the World

Paris, FR
Paris, France

Bioprojet

Forward Citations = 53

49 inventors:

goldMedal Jeanne-Marie Lecomte (22 out of 56 patents)

silverMedal Jean-Charles Schwartz (22 out of 62 patents)

bronzeMedal Xavier Ligneau (14 out of 20 patents)

4.  Marc Capet (12 out of 41 patents)

5.  Philippe Robert (12 out of 13 patents)

Please report any incorrect information to [email protected]
Loading…